Zavesca

(miglustat)
NO BOXED WARNING

Dosage & Administration

Renal ImpairmentAdjusted Creatinine Clearance
(in mL/min/1.73 m 2)
Recommendations
Mild50 – 70Start dose at 100 mg twice a day
Moderate30 – 50Start dose at 100 mg once a day
Severe<30Use is not recommended

Get Your Patient on Zavesca

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Zavesca Prescribing Information

Zavesca Prior Authorization Resources

Most recent state uniform prior authorization forms

Zavesca PubMed™ News